These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 30774330)
1. Improving antitumor outcomes for palliative intratumoral injection therapy through lecithin- chitosan nanoparticles loading paclitaxel- cholesterol complex. Chu XY; Huang W; Wang YL; Meng LW; Chen LQ; Jin MJ; Chen L; Gao CH; Ge C; Gao ZG; Gao CS Int J Nanomedicine; 2019; 14():689-705. PubMed ID: 30774330 [TBL] [Abstract][Full Text] [Related]
2. Low density lipoprotein mimic nanoparticles composed of amphipathic hybrid peptides and lipids for tumor-targeted delivery of paclitaxel. Qian J; Xu N; Zhou X; Shi K; Du Q; Yin X; Zhao Z Int J Nanomedicine; 2019; 14():7431-7446. PubMed ID: 31686815 [TBL] [Abstract][Full Text] [Related]
3. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation. Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377 [TBL] [Abstract][Full Text] [Related]
4. Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment. Song Y; Cai H; Yin T; Huo M; Ma P; Zhou J; Lai W Int J Nanomedicine; 2018; 13():1585-1600. PubMed ID: 29588586 [TBL] [Abstract][Full Text] [Related]
5. Hybrid Nanoparticle for Co-delivering Paclitaxel and Dihydroartemisinin to Exhibit Synergic Anticancer Therapeutics. Tran BN; Ninh TTK; Do TT; Do PT; Nguyen CN Curr Cancer Drug Targets; 2024; 24(12):1250-1261. PubMed ID: 38321897 [TBL] [Abstract][Full Text] [Related]
6. Redox-sensitive self-assembled nanoparticles based on alpha-tocopherol succinate-modified heparin for intracellular delivery of paclitaxel. Yang X; Cai X; Yu A; Xi Y; Zhai G J Colloid Interface Sci; 2017 Jun; 496():311-326. PubMed ID: 28237749 [TBL] [Abstract][Full Text] [Related]
7. Paclitaxel-loaded poly(glycolide-co-ε-caprolactone)-b-D-α-tocopheryl polyethylene glycol 2000 succinate nanoparticles for lung cancer therapy. Zhao T; Chen H; Dong Y; Zhang J; Huang H; Zhu J; Zhang W Int J Nanomedicine; 2013; 8():1947-57. PubMed ID: 23696703 [TBL] [Abstract][Full Text] [Related]
8. Self-Assembled Reduced Albumin and Glycol Chitosan Nanoparticles for Paclitaxel Delivery. Razi MA; Wakabayashi R; Goto M; Kamiya N Langmuir; 2019 Feb; 35(7):2610-2618. PubMed ID: 30673276 [TBL] [Abstract][Full Text] [Related]
9. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy. Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055 [No Abstract] [Full Text] [Related]
10. Improved safety and efficacy of a lipid emulsion loaded with a paclitaxel-cholesterol complex for the treatment of breast tumors. Ye J; Liu Y; Xia X; Meng L; Dong W; Wang R; Fu Z; Liu H; Han R Oncol Rep; 2016 Jul; 36(1):399-409. PubMed ID: 27175803 [TBL] [Abstract][Full Text] [Related]
11. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes. Jin M; Jin G; Kang L; Chen L; Gao Z; Huang W Int J Nanomedicine; 2018; 13():2405-2426. PubMed ID: 29719390 [TBL] [Abstract][Full Text] [Related]
12. Lipoprotein-Inspired Nanocarrier Composed of Folic Acid-Modified Protein and Lipids: Preparation and Evaluation of Tumor-Targeting Effect. Han M; Ji X; Li J; Ge Z; Luo B; Zhou K; Wang Q; Sun X; Zhang W; Li J Int J Nanomedicine; 2020; 15():3433-3445. PubMed ID: 32523342 [TBL] [Abstract][Full Text] [Related]
13. Development of paclitaxel loaded pegylated gelatin targeted nanoparticles for improved treatment efficacy in non-small cell lung cancer (NSCLC): an in vitro and in vivo evaluation study. Gu M; Luan J; Song K; Qiu C; Zhang X; Zhang M Acta Biochim Pol; 2021 Aug; 68(4):583-591. PubMed ID: 34355554 [TBL] [Abstract][Full Text] [Related]
14. Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer. Min SY; Byeon HJ; Lee C; Seo J; Lee ES; Shin BS; Choi HG; Lee KC; Youn YS Int J Pharm; 2015 Oct; 494(1):506-15. PubMed ID: 26315118 [TBL] [Abstract][Full Text] [Related]
15. Magnetic targeting of paclitaxel-loaded poly(lactic- Ganipineni LP; Ucakar B; Joudiou N; Bianco J; Danhier P; Zhao M; Bastiancich C; Gallez B; Danhier F; Préat V Int J Nanomedicine; 2018; 13():4509-4521. PubMed ID: 30127603 [TBL] [Abstract][Full Text] [Related]
16. Long-circulating self-assembled cholesteryl albumin nanoparticles enhance tumor accumulation of hydrophobic anticancer drug. Battogtokh G; Kang JH; Ko YT Eur J Pharm Biopharm; 2015 Oct; 96():96-105. PubMed ID: 26212785 [TBL] [Abstract][Full Text] [Related]
17. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells. Nag M; Gajbhiye V; Kesharwani P; Jain NK Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697 [TBL] [Abstract][Full Text] [Related]
18. pH-Sensitive Biocompatible Nanoparticles of Paclitaxel-Conjugated Poly(styrene-co-maleic acid) for Anticancer Drug Delivery in Solid Tumors of Syngeneic Mice. Dalela M; Shrivastav TG; Kharbanda S; Singh H ACS Appl Mater Interfaces; 2015 Dec; 7(48):26530-48. PubMed ID: 26528585 [TBL] [Abstract][Full Text] [Related]
19. A pH-Sensitive Polymeric Micellar System Based on Chitosan Derivative for Efficient Delivery of Paclitaxel. Han Y; Pan J; Liang N; Gong X; Sun S Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206347 [TBL] [Abstract][Full Text] [Related]
20. Chronic chemotherapy with paclitaxel nanoparticles induced apoptosis in lung cancer in vitro and in vivo. Zhao X; Fan J; Wu P; Wei C; Chen Q; Ming Z; Yan J; Yang L Int J Nanomedicine; 2019; 14():1299-1309. PubMed ID: 30863062 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]